Us Bancorp \De\ Neurocrine Biosciences Inc Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 3,864 shares of NBIX stock, worth $484,970. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,864

Previous 5,573 30.67%

Holding current value

$484,970

Previous $767,000 42.11%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$114.58 - $153.15 $195,817 - $261,733	-1,709 Reduced 30.67%	3,864 $444,000
Q2 2024 Aug 06, 2024	BUY	$130.86 - $143.19 $80,348 - $87,918	614 Added 12.38%	5,573 $767,000
Q1 2024 May 07, 2024	SELL	$130.4 - $143.74 $120,750 - $133,103	-926 Reduced 15.73%	4,959 $683,000
Q4 2023 Feb 09, 2024	BUY	$106.07 - $132.76 $55,368 - $69,300	522 Added 9.73%	5,885 $775,000
Q3 2023 Nov 03, 2023	SELL	$94.02 - $117.1 $527,076 - $656,462	-5,606 Reduced 51.11%	5,363 $603,000
Q2 2023 Aug 09, 2023	SELL	$89.53 - $104.87 $1.13 Million - $1.33 Million	-12,669 Reduced 53.6%	10,969 $1.03 Million
Q1 2023 May 09, 2023	BUY	$94.11 - $123.02 $65,500 - $85,621	696 Added 3.03%	23,638 $2.39 Million
Q4 2022 Feb 13, 2023	SELL	$106.72 - $127.06 $664,758 - $791,456	-6,229 Reduced 21.35%	22,942 $2.74 Million
Q3 2022 Oct 27, 2022	SELL	$92.03 - $107.81 $187,741 - $219,932	-2,040 Reduced 6.54%	29,171 $3.1 Million
Q2 2022 Aug 01, 2022	BUY	$75.79 - $100.07 $7,275 - $9,606	96 Added 0.31%	31,211 $3.04 Million
Q1 2022 May 11, 2022	BUY	$72.45 - $94.81 $690,013 - $902,970	9,524 Added 44.11%	31,115 $2.92 Million
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $703,309 - $937,922	-8,830 Reduced 29.03%	21,591 $1.84 Million
Q3 2021 Nov 10, 2021	SELL	$86.18 - $99.03 $35,592 - $40,899	-413 Reduced 1.34%	30,421 $2.92 Million
Q2 2021 Aug 05, 2021	BUY	$89.43 - $102.27 $155,608 - $177,949	1,740 Added 5.98%	30,834 $3 Million
Q1 2021 Apr 28, 2021	BUY	$87.57 - $119.4 $645,040 - $879,500	7,366 Added 33.9%	29,094 $2.83 Million
Q4 2020 Feb 04, 2021	BUY	$86.91 - $108.33 $308,443 - $384,463	3,549 Added 19.52%	21,728 $2.08 Million
Q3 2020 Nov 10, 2020	BUY	$96.16 - $135.15 $1.32 Million - $1.85 Million	13,704 Added 306.23%	18,179 $1.75 Million
Q2 2020 Aug 07, 2020	BUY	$85.09 - $130.36 $55,733 - $85,385	655 Added 17.15%	4,475 $546,000
Q1 2020 May 13, 2020	BUY	$75.11 - $113.76 $826 - $1,251	11 Added 0.29%	3,820 $330,000
Q4 2019 Feb 04, 2020	BUY	$86.8 - $118.57 $59,458 - $81,220	685 Added 21.93%	3,809 $410,000
Q3 2019 Nov 08, 2019	BUY	$83.82 - $101.5 $20,955 - $25,375	250 Added 8.7%	3,124 $281,000
Q2 2019 Aug 13, 2019	SELL	$72.24 - $91.27 $866 - $1,095	-12 Reduced 0.42%	2,874 $244,000
Q1 2019 May 08, 2019	BUY	$69.31 - $91.53 $111,519 - $147,271	1,609 Added 126.0%	2,886 $254,000
Q4 2018 Feb 13, 2019	BUY	$68.32 - $124.36 $32,725 - $59,568	479 Added 60.03%	1,277 $91,000
Q3 2018 Nov 01, 2018	BUY	$98.88 - $125.85 $2,768 - $3,523	28 Added 3.64%	798 $99,000
Q2 2018 Aug 08, 2018	BUY	$75.3 - $105.99 $4,066 - $5,723	54 Added 7.54%	770 $75,000
Q1 2018 May 08, 2018	BUY	$75.88 - $92.43 $24,129 - $29,392	318 Added 79.9%	716 $59,000
Q4 2017 Feb 02, 2018	SELL	$58.53 - $77.59 $31,255 - $41,433	-534 Reduced 57.3%	398 $31,000
Q3 2017 Nov 13, 2017	BUY	$47.97 - $61.28 $44,708 - $57,112	932	932 $57,000

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account